Pfizer-BioNTech to seek FDA approval for third dose of COVID-19 vaccine

Pfizer and BioNTech have announced that they would seek the FDA's approval for the third dose of their COVID-19 vaccine to boost its efficacy, as the Delta variant is increasingly becoming a global dominant.